Portuguese
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

dizziness/obesidade

O link é salvo na área de transferência
Página 1 a partir de 172 resultados

Impact of dizziness and obesity on the prevalence of falls and fall-related injuries.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE Quantify the relationships between dizziness, falls, and obesity among adults. METHODS Cross-sectional analysis of a national health survey. METHODS Adult respondents in the 2008 National Health Interview Survey balance module were analyzed. With demographic information, data for balance

Dizziness and Falls in Obese Inpatients Undergoing Metabolic Rehabilitation.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE The relationship between dizziness and falls in the obese population is a relatively unexplored issue. The aims of the present study were to define the 1-year prevalence of dizziness in an obese inpatient population undergoing metabolic rehabilitation and to investigate possible
BACKGROUND The symptomatic sick sinus syndrome presents a classic indication for the implantation of a dual-chamber pacemaker according to the current national and international guidelines. However, in cases where dizziness and near syncope due to a sinus node dysfunction are found together with

In response to Impact of dizziness and obesity on the prevalence of falls and fall-related injuries.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se

In reference to Impact of dizziness and obesity of the prevalence of falls and fall-related injuries.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
A 50-year-old very obese man had suffered from hypertension for more than 20 years and had undergone various treatment regimens, the last being with an ACE inhibitor. Since his hypertension had nevertheless increased, and he developed dizziness and headaches, a combination of ACE-inhibitor and
BACKGROUND Rimonabant, a selective cannabinoid type 1 receptor blocker, reduces bodyweight and improves cardiovascular and metabolic risk factors in non-diabetic overweight or obese patients. The aim of the RIO-Diabetes trial was to assess the efficacy and safety of rimonabant in overweight or obese

Rimonabant: a novel selective cannabinoid-1 receptor antagonist for treatment of obesity.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE The pharmacology, pharmacokinetics, clinical efficacy, safety, drug interactions, and dosage and administration of rimonabant in the treatment of obesity and related metabolic factors are reviewed. CONCLUSIONS Discovery of the cannabinoid receptors has led to the development of rimonabant,
Taranabant is a novel cannabinoid CB-1 receptor (CB1R) inverse agonist in clinical development for the treatment of obesity. This double-blind, randomized, placebo-controlled, single oral dose study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of taranabant (0.5-600 mg)

Fenfluramine lowers plasma norepinephrine in overweight subjects.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
The effect of fenfluramine on sympathetic nervous system activity was determined in 12 normotensive, obese men. Supine plasma norepinephrine (NE) concentrations decreased (p less than 0.001) from pretherapy levels (298 +/- 39 pg/ml) after one (166 +/- 30 pg/ml) and four weeks (171 +/- 28 pg/ml) of
OBJECTIVE To evaluate the efficacy and safety of taranabant in overweight and obese patients with type 2 diabetes mellitus (T2DM). METHODS This was a multicenter, double-blind, randomized, placebo-controlled study in overweight and obese patients with T2DM (ages > or = 18 and < or = 75 years) with a

Efficacy and Safety of Lorcaserin in Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
Lorcaserin is a novel, selective 5-hydroxytryptamine 2C serotonin receptor agonist, approved for the treatment of obesity. Several phase 3 randomized controlled trials (RCTs) trials have shown a significant reduction in body weight with lorcaserin.We

Short-term topiramate treatment does not improve insulin sensitivity or secretion in obese insulin-resistant women.

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE Long-term treatment with topiramate reduces body weight and improves insulin sensitivity in obese humans. Our aim was to evaluate the effect of topiramate treatment for 4 weeks on insulin sensitivity and secretion, independent of weight loss. METHODS Randomized, double-blind, crossover,
OBJECTIVE To compare the Galletti-Contrino manoeuvre with the more widely used Semont-Toupet in overweight subjects presenting with benign paroxysmal positional vertigo (BPBV) of vertical semicircular canals (posterior and anterior canals). METHODS Prospective cohort study. METHODS 204 patients (BMI

[Effectiveness and safety of Very Low Calory Diets in obese patients].

Apenas usuários registrados podem traduzir artigos
Entrar Inscrever-se
OBJECTIVE To evaluate effectiveness, safety and adherence of Very Low Calory Diet (VLCD) in patients with obesity. METHODS Observational prospective descriptive study. Patients with BMI >30 kg/m2 who started VLCD were included. We arranged 3 pharmacotherapeutical consultations, picking up the
Junte-se à nossa
página do facebook

O mais completo banco de dados de ervas medicinais apoiado pela ciência

  • Funciona em 55 idiomas
  • Curas herbais apoiadas pela ciência
  • Reconhecimento de ervas por imagem
  • Mapa GPS interativo - marcar ervas no local (em breve)
  • Leia publicações científicas relacionadas à sua pesquisa
  • Pesquise ervas medicinais por seus efeitos
  • Organize seus interesses e mantenha-se atualizado com as notícias de pesquisa, testes clínicos e patentes

Digite um sintoma ou doença e leia sobre ervas que podem ajudar, digite uma erva e veja as doenças e sintomas contra os quais ela é usada.
* Todas as informações são baseadas em pesquisas científicas publicadas

Google Play badgeApp Store badge